Blood-brain barrier leakage hotspots collocating with brain lesions due to sporadic and monogenic small vessel disease.
Blood-brain barrier
cerebral small vessel disease
dynamic-contrast enhanced imaging
lacunar
white matter hyperintensities
Journal
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism
ISSN: 1559-7016
Titre abrégé: J Cereb Blood Flow Metab
Pays: United States
ID NLM: 8112566
Informations de publication
Date de publication:
09 2023
09 2023
Historique:
medline:
10
8
2023
pubmed:
3
5
2023
entrez:
3
5
2023
Statut:
ppublish
Résumé
Blood-brain barrier (BBB) is known to be impaired in cerebral small vessel disease (SVD), and is measurable by dynamic-contrast enhancement (DCE)-MRI. In a cohort of 69 patients (42 sporadic, 27 monogenic SVD), who underwent 3T MRI, including DCE and cerebrovascular reactivity (CVR) sequences, we assessed the relationship of BBB-leakage hotspots to SVD lesions (lacunes, white matter hyperintensities (WMH), and microbleeds). We defined as hotspots the regions with permeability surface area product highest decile on DCE-derived maps within the white matter. We assessed factors associated with the presence and number of hotspots corresponding to SVD lesions in multivariable regression models adjusted for age, WMH volume, number of lacunes, and SVD type. We identified hotspots at lacune edges in 29/46 (63%) patients with lacunes, within WMH in 26/60 (43%) and at the WMH edges in 34/60 (57%) patients with WMH, and microbleed edges in 4/11 (36%) patients with microbleeds. In adjusted analysis, lower WMH-CVR was associated with presence and number of hotspots at lacune edges, and higher WMH volume with hotspots within WMH and at WMH edges, independently of the SVD type. In conclusion, SVD lesions frequently collocate with high BBB-leakage in patients with sporadic and monogenic forms of SVD.
Identifiants
pubmed: 37132279
doi: 10.1177/0271678X231173444
pmc: PMC10414006
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1490-1502Subventions
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
Pays : United Kingdom
Organisme : Wellcome Trust
ID : 104916/Z/14/Z
Pays : United Kingdom
Références
Lancet Neurol. 2013 Aug;12(8):822-38
pubmed: 23867200
Brain Commun. 2022 Sep 26;4(5):fcac245
pubmed: 36267331
Neuroradiology. 2016 May;58(5):475-85
pubmed: 26833053
Ann Neurol. 2009 Feb;65(2):194-202
pubmed: 19260033
Neurology. 2022 May 23;:
pubmed: 35606147
J Neurol Neurosurg Psychiatry. 2001 Jan;70(1):9-14
pubmed: 11118240
Magn Reson Med. 2021 Oct;86(4):1888-1903
pubmed: 34002894
Stroke. 2017 Oct;48(10):2799-2804
pubmed: 28855392
Brain. 2021 Jun 22;144(5):1361-1371
pubmed: 34000009
Neuroimage. 2016 Jan 15;125:446-455
pubmed: 26477653
Front Neurol. 2021 Oct 28;12:756887
pubmed: 34777227
Neurology. 2014 Sep 30;83(14):1228-34
pubmed: 25165388
Circulation. 2022 Apr 5;145(14):1040-1052
pubmed: 35050683
J Neurol Neurosurg Psychiatry. 2010 Feb;81(2):192-7
pubmed: 19710048
Alzheimers Dement (Amst). 2019 Feb 26;11:191-204
pubmed: 30859119
Magn Reson Imaging. 2011 Apr;29(3):305-14
pubmed: 21030178
Stroke. 2020 Jan;51(1):12-20
pubmed: 31752611
AJR Am J Roentgenol. 1987 Aug;149(2):351-6
pubmed: 3496763
Neuroimage. 2021 Apr 15;230:117786
pubmed: 33497771
Int J Stroke. 2015 Apr;10(3):376-81
pubmed: 23692610
Cereb Circ Cogn Behav. 2021 Jun 26;2:100020
pubmed: 36324725
J Alzheimers Dis. 2015;48(3):711-20
pubmed: 26402072
Stroke. 2015 Sep;46(9):2413-8
pubmed: 26205374
Brain. 2013 Sep;136(Pt 9):2717-26
pubmed: 23864274
Neuroimage. 2002 Oct;17(2):825-41
pubmed: 12377157
Stroke. 2011 Aug;42(8):2158-63
pubmed: 21719768
Alzheimers Dement. 2019 Jun;15(6):840-858
pubmed: 31031101
Lancet Neurol. 2019 Jul;18(7):684-696
pubmed: 31097385
J Stroke. 2015 Jan;17(1):7-16
pubmed: 25692103